The five-year survival rate for invasive lobular carcinoma is high compared to other types of cancer — nearly 100% when treated early. If the cancer has spread to nearby tissues, the five-year survival rate is about 93%. If it has metastasized to other areas of your body, the five-year survival rate is 22%.
People also ask
What is the deadliest form of breast cancer?
Is lobular carcinoma aggressive?
What is the most invasive breast cancer?
What is the 10-year survival rate for breast cancer?
Survival rate · Stage 0 or 1: nearly 100 percent · Stage 2: about 93 percent · Stage 3: around 72 percent · Stage 4: approximately 22 percent ...
The 5- and 30-year corrected survival rates of women with ILC were 78% and 50%, respectively, compared with 63% and 37% for women with IDC (P = 0.001). Small ...
Jul 22, 2021 · We noticed an improved survival for patients with ILC during the first five years, excess mortality rate ratio (EMRR) 0.64 (CI 95 % 0.53–0.77).
However, a 2024 studyTrusted Source found that the overall 5-year survival rate for ILC was quite high, at 88.6%, and the 10-year survival rate was 73.6%.
Nov 8, 2023 · Although patients with ILC had better survival during the first 10 years following diagnosis, they experienced poorer BCSS outcomes after 10 ...
Nov 1, 1997 · The 5- and 30-year corrected survival rates of women with ILC were 78% and 50%, respectively, compared with 63% and 37% for women with IDC (P = ...
Mar 17, 2023 · Localized (cancer hasn't spread outside the breast): 99% live at least 5 years. Regional (cancer has spread to lymph nodes near the breast): 85% ...
“Early-stage breast cancers carry a higher survival rate than advanced stages. ... In general, with modern treatments, the prognosis of lobular carcinoma is ...
Dec 22, 2020 · The median follow-up time for overall survival was 54 months (95% CI, 53.29–54.71 months) in the ILC cohort and 57 months (95% CI, 56.28–57.72 ...
People also search for